Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
RNA
$7.58
+1.07%
RNA
· Atrium Therapeutics, Inc.
$7.58
+0.08 (+1.07%)
At close · Nov 13
Return incl. dividend (before tax)
Market Cap
$128.29M
Shares
21.57M
Volume · Nov 13
4740
Avg daily vol (3M)
288.66K
All webcasts
Earnings call · FY2026 Q1
Atrium Therapeutics, Inc. (RNA) Q1 2026 Earnings Call
Revenue
$19.64M
+1148.3% YoY
Diluted EPS
-$0.97
Net income
-$16.63M
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
8 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed May 14, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 14, 2026 · complete as-filed document